The hypercholesterolemia treatment market is booming due to widespread adoption of statins, emerging therapies like PCSK9 inhibitors, inclisiran, and bempedoic acid in response to cardiovascular disease burden and updated clinical guidelines. https://www.datamintelligence.com/research-report/hypercholesterolemia-treatment-market